|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$52.96 |
$53.15 |
$52.26 |
$52.82 |
1.83M | 04/19/2024 |
$52.97 |
$53.00 |
$52.00 |
$52.35 |
2.18M | 04/22/2024 |
$52.43 |
$52.62 |
$51.88 |
$51.92 |
1.75M | 04/23/2024 |
$52.00 |
$52.22 |
$51.39 |
$51.65 |
2.49M | 04/24/2024 |
$51.65 |
$51.84 |
$51.14 |
$51.74 |
1.56M |
|
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. JAKAFI (ruxolitinib) is Co.'s initial product approved by the U.S. Food and Drug Administration for the treatment of adults with intermediate or high-risk myelofibrosis, for the treatment of adults with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea, for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older and for the treatment of chronic GVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older. | |
|
Incyte (INCY) has the following price history information. Looking back at INCY historical stock prices for the last five trading days, on April 18, 2024, INCY opened at $52.96, traded as high as $53.15 and as low as $52.26, and closed at $52.82. Trading volume was a total of 1.83M shares. On April 19, 2024, INCY opened at $52.97, traded as high as $53.00 and as low as $52.00, and closed at $52.35. Trading volume was a total of 2.18M shares. On April 22, 2024, INCY opened at $52.43, traded as high as $52.62 and as low as $51.88, and closed at $51.92. Trading volume was a total of 1.75M shares. On April 23, 2024, INCY opened at $52.00, traded as high as $52.22 and as low as $51.39, and closed at $51.65. Trading volume was a total of 2.49M shares. On April 24, 2024, INCY opened at $51.65, traded as high as $51.84 and as low as $51.14, and closed at $51.74. Trading volume was a total of 1.56M shares.
INCY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Incyte shares, starting with a $10,000 purchase of INCY, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$45.08 |
|
End price/share: |
$51.74 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
14.77% |
|
Average Annual Total Return: |
1.39% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$11,479.81 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $52.82 | 04/19/2024 | $52.35 | 04/22/2024 | $51.92 | 04/23/2024 | $51.65 | 04/24/2024 | $51.74 |
|
|